CSIMarket
 


Replimune Group Inc   (REPL)
Other Ticker:  
 

Replimune Group Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Replimune Group Inc in the third quarter 2024?
Replimune Group Inc recorded a cumulative net loss of $-210 million during 12 months ending in the third quarter 2024, resulting in a negative return on equity (ROE) of -42.94%.

Within the Biotechnology & Pharmaceuticals industry 29 other companies had a higher return on equity. While Return on equity, overall ranking has advanced in the quarter, so far to 2282, from total ROE ranking in the second quarter 2024 at 3004.

What is ROE?



Return On Equity (Dec 31 2023)
III. Quarter
(Sep 30 2023)
II. Quarter
(Jun 30 2023)
I. Quarter
(Mar 31 2023)
IV. Quarter
(Dec 31 2022)
III. Quarter
Y / Y Equity Change -29.19 % 21.12 % 25.29 % 35.03 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -210 -199 -182 -174 -157
Return On Equity (TTM) -42.94 % -37.29 % -35.45 % -35.84 % -34.81 %
REPL's Total Ranking # 2282 # 3004 # 3063 # 3136 # 3561
Equity (TTM) in Millions 422 465 514 555 595
Seq. Equity Change -9.38 % -9.5 % -7.43 % -6.73 % 55.01 %
Seq. Net Income Change - - - - -

Return On Equity Company Ranking
Within: No.
Industry # 30
Sector # 242
Overall # 2282

Return On Equity Statistics
High Average Low
-8.97 %
-26.35 %
-42.94 %
(Jun 30 2020)   (Dec 31 2023)





REPL Annual Return On Equity (Mar 31 2023)
2023
(Mar 31 2022)
2022
(Mar 31 2021)
2021
(Mar 31 2020)
2019

Total Equity in Millions 555 411 499 184 0
Y / Y Equity Change 35.03 % -17.54 % 171.46 % - -
Net Income in Millions -174 -118 -81 -53 0
Y / Y Net Income Change - - - - -
Return On Equity -31.39 % -28.7 % -16.22 % -28.64 % -





More Return On Equity Ratios
Biotechnology & Pharmaceuticals Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
REPL's' Return on Equity at Yahoo Finance
REPL's Roe Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Roe for REPL's Competitors
Return On Equity for Replimune Group Inc 's Suppliers
Roe for REPL's Customers




Companies with similar Return On Equity at Dec 31 2023, within Healthcare Sector ROE


Date modified: 2024-02-08T15:37:20+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com